m+Medelevator.RU
← Поиск публикаций
Clinical laboratory · 2023

Molecular Evaluation of β-Lactamase (blaSHV, blaTEM, blaCTX-M) Genes in Multidrug Resistant of Klebsiella Pneumoniae.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Nargesian Mansooreh, Saffari Mahmood, Zargar Mohsen

Аннотация

BACKGROUND: Klebsiella is an opportunistic pathogen, which is the most common causes of nosocomial infections. To date, the prevalence of ESBL-producing pathogens has increased and is associated with mortality, morbidity, and healthcare costs. The aim of this investigation was to determine the frequency of blaSHV, blaTEM, and blaCTX-M genes from Klebsiella pneumonia isolated from patients with UTI in the city of Qom.

METHODS: In the cross-sectional study, a total of 500 urinary samples were cultured in MacConkey agar and identified using the biochemical test. For a total of 340 positive K. pneumonia samples the antimicrobial susceptibility was determined using the Kirby-Bauer disc diffusion approach. For molecular genotyping, the frequencies of blaSHV, blaCTX-M, and blaTEM genes were determined using a polymerase chain reaction (PCR) method.

RESULTS: Our finding revealed that a total of 340 K. pneumonia isolates 110 isolates (32.35%) were ESBL producers by the phenotypic method. All of these isolates were assessed by PCR for blaSHV, blaCTX-M, and blaTEM genes. The PCR results demonstrated that the frequencies of blaTEM, blaCTX-M, and blaSHV genes were 59.09% (65 isolates), 74.54% (82 isolates), and 74.54% (82 isolates), respectively.

CONCLUSIONS: According to our findings, with the higher prevalence of ESBL-producing isolates in the clinical, early detection, and follow-up procedures are critical strategies to the prevention of the spread of multidrug resistant isolates.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты